CSF2 and neoplasm: The virus was further modified by the insertion of a gene encoding the expression of human granulocyte macrophage colony-stimulating factor, GM-CSF, to promote anti-tumor immune responses by recruiting and activating antigen-presenting cells, APCs [62].